Back to DEUTSCHE BANK AG\ DEUTSCHE BANK AG\

ACRSACRS
Showing 8 of 31 quarters

Position history for DEUTSCHE BANK AG\DEUTSCHE BANK AG\'s holdings in ACLARIS THERAPEUTICS INC

Yes. Deutsche Bank holds 1,040,955 shares of ACRS (Aclaris Therapeutics), worth $5.5M, as of its Q2 2026 13F filing. It increased the position by 43,105 shares (+4.3%) from Q1 2026. Deutsche Bank has held ACRS in every 13F on record since Q4 2018, 31 quarterly filings.

Current Value

$5.5M

Current Shares

1M

Total Value Change

+$4.4M

Total Shares Change

+117,642

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1M
+4.3%
$5.5M0.0%$5.29
28
2026-Q1
Increased
997,850
+1.1%
$3.7M0.0%$3.75
27
2025-Q4
Increased
987,351
+6.9%
$3M0.0%$3.01
28
2025-Q3
Decreased
923,313
-8.3%
$1.8M0.0%$1.90
0
2025-Q2
Increased
1M
+9.0%
$1.4M0.0%$1.42
28
2025-Q1
Unchanged
923,313
0.0%
$1.4M0.0%$1.53
0
2024-Q4
Unchanged
923,313
0.0%
$2.3M0.0%$2.48
0
2024-Q3
Unchanged
923,313
0.0%
$1.1M0.0%$1.15
0

Other major holders of ACRS: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used